Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs

Biomaterials

Volumn 33, Issue 19, 2012, Pages 4861-4871

  Lee, Ji hye ^a   Jung, Min Jin ^a   Hwang, Yong Hwa ^a   Lee, Young Jun ^a   Lee, Seungsoo ^b   Lee, Dong Yun ^a   Shin, Heungsoo ^a  

^a Hanyang University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Heparin; MRI (magnetic resonance imaging); Stem cell; Superparamagnetic iron oxide(SPIO)

Indexed keywords

ADIPOGENIC; CELLULAR LABELING; CONTRAST AGENT; CYTOSOLS; EFFECTIVE CONTRAST AGENTS; EXPOSURE-TIME; HEPARIN; HIGH RESOLUTION; HUMAN MESENCHYMAL STEM CELLS (HMSCS); HYPOINTENSITY; IN-VITRO; IN-VIVO; INHIBITION ASSAYS; LOW TEMPERATURES; LOW TOXICITY; MR IMAGING; MRI (MAGNETIC RESONANCE IMAGING); MRI CONTRAST AGENTS; NUDE MICE; OSTEOGENIC; PRUSSIAN BLUE; REGENERATIVE MEDICINE; STEM CELL LABELING; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDES; THERAPEUTIC POTENTIALS; TRANSFECTION AGENTS; UNFRACTIONATED HEPARINS;

IRON OXIDES; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; NANOPARTICLES; POLYSACCHARIDES; STEM CELLS; SUPERPARAMAGNETISM;

CELL CULTURE;

DEXTRAN; HEPARIN; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ADIPOGENESIS; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL KINETICS; CELL LABELING; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; EXPOSURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; LOW TEMPERATURE PROCEDURES; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLAST; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL DIFFERENTIATION; CONTRAST MEDIA; DEXTRANS; HELA CELLS; HEPARIN; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE;

MUS MUSCULUS; SPIO;

EID: 84859870962     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.03.035     Document Type: Article

References (44)

1. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
2. Lindvall O., Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006, 441:1094-1096.
3. Reddi A.H., Becerra J., Andrades J.A. Nanomaterials and hydrogel scaffolds for articular cartilage regeneration. Tissue Eng Part B Rev 2011, 17:301-305.
4. Jw Bulte, Douglas T., Witwer B., Sc Zhang, Bk Lewis, van Gelderen P., et al. Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents. Acad Radiol 2002, 9:s332-s335.
5. Jw Bulte, Sc Zhang, van Gelderen P., Herynek V., Ek Jordan, Ch Janssen, et al. Magnetically labeled glial cells as cellular MR contrast agents. Acad Radiol 2002, 9:S148-S150.
6. Modo M., Cash D., Mellodew K., Williams S.C., Fraser S.E., Meade T.J., et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002, 17:803-811.
7. Luker G.D., Piwnica-Worms D. Molecular imaging in vivo with PET and SPECT. Acad Radiol 2001, 8:4-14.
8. Mahmood U., Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2003, 2:489-496.
9. Wang Y.X., Hussain S.M., Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2319-2331.
10. Corot C., Robert P., Idee J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006, 58:1471-1504.
11. Frank J.A., Miller B.R., Arbab A.S., Zywicke H.A., Jordan E.K., Lewis B.K., et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003, 228:480-487.
12. Ittrich H., Lange C., Togel F., Zander A.R., Dahnke H., Westenfelder C., et al. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging 2007, 25:1179-1191.
13. Berry C.C., Wells S., Charles S., Curtis A.S. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003, 24:4551-4557.
14. Reddy A.M., Kwak B.K., Shim H.J., Ahn C., Lee H.S., Suh Y.J., et al. In vivo tracking of mesenchymal stem cells labeled with a novel chitosan-coated superparamagnetic iron oxide nanoparticles using 3.0T MRI. J Korean Med Sci 2010, 25:211-219.
15. Olsen D., Yang C., Bodo M., Chang R., Leigh S., Baez J., et al. Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev 2003, 55:1547-1567.
16. Gupta A.K., Curtis A.S. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci Mater Med 2004, 15:493-496.
17. Shan G.B., Xing J.M., Luo M.F., Liu H.Z., Chen J.Y. Immobilization of Pseudomonas delafieldii with magnetic polyvinyl alcohol beads and its application in biodesulfurization. Biotechnol Lett 2003, 25:1977-1981.
18. Weissleder R., Cheng H.C., Bogdanova A., Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997, 7:258-263.
19. Qian Z.M., Li H., Sun H., Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002, 54:561-587.
20. So P.W., Kalber T., Hunt D., Farquharson M., Al-Ebraheem A., Parkes H.G., et al. Efficient and rapid labeling of transplanted cell populations with superparamagnetic iron oxide nanoparticles using cell surface chemical biotinylation for in vivo monitoring by MRI. Cell Transplant 2010, 19:419-429.
21. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000, 18:410-414.
22. Schafer R., Kehlbach R., Wiskirchen J., Bantleon R., Pintaske J., Brehm B.R., et al. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 2007, 244:514-523.
23. Schafer R., Kehlbach R., Muller M., Bantleon R., Kluba T., Ayturan M., et al. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy 2009, 11:68-78.
24. Balakumaran A., Pawelczyk E., Ren J., Sworder B., Chaudhry A., Sabatino M., et al. Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness". PLoS One 2010, 5:e11462.
25. Xu Q., Zhang H.T., Liu K., Rao J.H., Liu X.M., Wu L., et al. In vitro and in vivo magnetic resonance tracking of Sinerem-labeled human umbilical mesenchymal stromal cell-derived Schwann cells. Cell Mol Neurobiol 2011, 31:365-375.
26. Arbab A.S., Yocum G.T., Wilson L.B., Parwana A., Jordan E.K., Kalish H., et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004, 3:24-32.
27. Bauer M., Kristensen B.W., Meyer M., Gasser T., Widmer H.R., Zimmer J., et al. Toxic effects of lipid-mediated gene transfer in ventral mesencephalic explant cultures. Basic Clin Pharmacol Toxicol 2006, 98:395-400.
28. Lee D. Highly effective T2 MR contrast agent based on heparinized superparamagnetic iron oxide nanoparticles. Macromol Res 2011, 19:843-847.
29. Delcroix G.J., Jacquart M., Lemaire L., Sindji L., Franconi F., Le Jeune J.J., et al. Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain Res 2009, 1255:18-31.
30. Heymer A., Haddad D., Weber M., Gbureck U., Jakob P.M., Eulert J., et al. Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials 2008, 29:1473-1483.
31. Jing X.H., Yang L., Duan X.J., Xie B., Chen W., Li Z., et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine 2008, 75:432-438.
32. Wang L., Deng J., Wang J., Xiang B., Yang T., Gruwel M., et al. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells. Magn Reson Imaging 2009, 27:108-119.
33. Chen Y.C., Hsiao J.K., Liu H.M., Lai I.Y., Yao M., Hsu S.C., et al. The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Toxicol Appl Pharmacol 2010, 245:272-279.
34. Kostura L., Kraitchman D.L., Mackay A.M., Pittenger M.F., Bulte J.W. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004, 17:513-517.
35. Arbab A.S., Yocum G.T., Kalish H., Jordan E.K., Anderson S.A., Khakoo A.Y., et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223.
36. Moon H.J., Yun Y.P., Han C.W., Kim M.S., Kim S.E., Bae M.S., et al. Effect of heparin and alendronate coating on titanium surfaces on inhibition of osteoclast and enhancement of osteoblast function. Biochem Biophys Res Commun 2011, 413:194-200.
37. Shen H., Hu X., Yang F., Bei J., Wang S. Cell affinity for bFGF immobilized heparin-containing poly(lactide-co-glycolide) scaffolds. Biomaterials 2011, 32:3404-3412.
38. Guzman R., Uchida N., Bliss T.M., He D., Christopherson K.K., Stellwagen D., et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci USA 2007, 104:10211-10216.
39. Wilhelm C., Billotey C., Roger J., Pons J.N., Bacri J.C., Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003, 24:1001-1011.
40. Pawelczyk E., Arbab A.S., Pandit S., Hu E., Frank J.A. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed 2006, 19:581-592.
41. Liu Z.Y., Wang Y., Liang C.H., Li X.H., Wang G.Y., Liu H.J., et al. In vitro labeling of mesenchymal stem cells with superparamagnetic iron oxide by means of microbubble-enhanced US exposure: initial experience. Radiology 2009, 253:153-159.
42. Hu S.L., Zhang J.Q., Hu X., Hu R., Luo H.S., Li F., et al. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J Cell Biochem 2009, 108:529-535.
43. Bulte J.W., Kraitchman D.L., Mackay A.M., Pittenger M.F. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 2004, 104:3410-3412. author reply 2-3.
44. Kuo Y.C., Shih K.H., Yang J.T. Capillary electrophoresis of bone marrow stromal cells with uptake of heparin-functionalized poly(lactide-co-glycolide) nanoparticles during differentiation towards neurons. Electrophoresis 2010, 31:315-323.